XML 32 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
AOCI
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
NCI
NCI
Cumulative Effect, Period of Adoption, Adjustment
BALANCE, beginning of year (in shares) at Dec. 31, 2017     139,918                
Beginning balance at Dec. 31, 2017 $ 3,403,361 $ (327,602) $ 1,399 $ 88,222 $ (402,543) $ 3,566,194 $ (326,639) $ 3,253,272 $ (326,639) $ 150,089 $ (963)
Increase (Decrease) in Shareholders' Equity                      
Net earnings (loss) 232,853         173,468   173,468   59,385  
OCI (143,227)       (140,988)     (140,988)   (2,239)  
Dividends (118,716)     153   (118,869)   (118,716)      
Distributions to NCI (63,523)                 (63,523)  
Capital contributions by NCI 5,128                 5,128  
Other NCI transactions 3,580     5,329       5,329   (1,749)  
Stock-based plan activity (in shares)     833                
Stock-based plan activity $ 38,421   $ 8 38,413       38,421      
Repurchase of common stock (in shares) (1,100)   (1,097)                
Repurchase of common stock $ (50,022)   $ (11) (50,011)       (50,022)      
BALANCE, end of year (in shares) at Dec. 31, 2018     139,654                
Ending balance at Dec. 31, 2018 $ 2,980,253   $ 1,396 82,106 (543,531) 3,294,154   2,834,125   146,128  
Ending balance (ASC 842) at Dec. 31, 2018   20,544         20,544   20,544    
Ending balance (ASC 606) at Dec. 31, 2018   11,934         11,934   11,934    
Increase (Decrease) in Shareholders' Equity                      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201409Member                    
Net earnings (loss) $ (1,553,122)         (1,522,164)   (1,522,164)   (30,958)  
OCI 162,308       163,658     163,658   (1,350)  
Dividends (103,252)     304   (103,556)   (103,252)      
Distributions to NCI (33,674)                 (33,674)  
Capital contributions by NCI 64,646                 64,646  
Other NCI transactions 545     48,997       48,997   (48,452)  
Stock-based plan activity (in shares)     520                
Stock-based plan activity 33,910   $ 3 33,907       33,910      
BALANCE, end of year (in shares) at Dec. 31, 2019     140,174                
Ending balance at Dec. 31, 2019 1,584,092 $ (1,977) $ 1,399 165,314 (379,873) 1,700,912 $ (1,977) 1,487,752 $ (1,977) 96,340  
Increase (Decrease) in Shareholders' Equity                      
Net earnings (loss) (366,791)         (435,046)   (435,046)   68,255  
OCI (36,150)       (37,033)     (37,033)   883  
Dividends (14,120)         (14,120)   (14,120)      
Distributions to NCI (23,184)                 (23,184)  
Capital contributions by NCI 110,051                 110,051  
Other NCI transactions (9,266)     10,099       10,099   (19,365)  
Stock-based plan activity (in shares)     541                
Stock-based plan activity 20,572   $ 5 20,527   40   20,572      
BALANCE, end of year (in shares) at Dec. 31, 2020     140,715                
Ending balance at Dec. 31, 2020 $ 1,263,227   $ 1,404 $ 195,940 $ (416,906) $ 1,249,809   $ 1,030,247   $ 232,980  
Increase (Decrease) in Shareholders' Equity                      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201904Member